News Releases
Viewing Category: Erbitux
-
MONTREAL, CANADA — September 30, 2009
Erbitux™ Now Available in Ontario and BC for Patients With Advanced Colorectal Cancer
Categories: Erbitux | Metastatic colorectal cancer
-
MONTREAL, CANADA — October 29, 2008
Bristol-Myers Squibb Canada Commercializes Erbitux™ for Advanced Colorectal Cancer
ERBITUX offers patients a new option for treating the disease and receives approval from Health Canada for the treatment of head and neck cancer
Categories: Erbitux | Metastatic colorectal cancer
-
MONTREAL, CANADA — September 15, 2005
New Treatment Option for Second Leading Cause of Cancer Deaths in Canada
Health Canada approves Erbitux® for the treatment of metastatic colorectal cancer
Categories: Erbitux | Metastatic colorectal cancer
